EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Biochemical Determinants for Diagnosis and Prediction of Severity in 5q Spinal Muscular Atrophy Using 1H-Nuclear Magnetic Resonance Metabolic Profiling in Patient-Derived Biofluids

Afshin Saffari iD, Moritz Niesert iD, Claire Cannet, Astrid Blaschek iD, Andreas Hahn, Jessika Johannsen, Musa Kockaya, Heike Kölbel iD, Georg F Hoffmann iD, Peter Claus iD, Stefan Kölker iD, Wolfgang Müller-Felber und 8 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252212123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Afshin Saffari und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Child Neurology and Metabolic Medicine, Department of Pediatrics I, Center for Pediatrics and Adolescent Medicine, Medical Faculty Heidel…. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal, Severity of Illness Index. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biogen (United States), Dietmar Hopp Stiftung, Biogen, Inc., Cambridge, USA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explores the potential of 1H-NMR spectroscopy-based metabolic profiling in various biofluids as a diagnostic and predictive modality to assess disease severity in individuals with 5q spinal muscular atrophy. A total of 213 biosamples (urine, plasma, and CSF) from 153 treatment-naïve patients with SMA across five German centers were analyzed using 1H-NMR spectroscopy. Prediction models were developed using machine learning algorithms which enabled the patients with SMA to be grouped according to disease severity. A quantitative enrichment analysis was employed to identify metabolic pathways associated with disease progression. The results demonstrate high sensitivity (84–91%) and specificity (91–94%) in distinguishing treatment-naïve patients with SMA from controls across all biofluids. The urinary and plasma profiles differentiated between early-onset (type I) and later-onset (type II/III) SMA with over 80% accuracy. Key metabolic differences involved alterations in energy and amino acid metabolism. This study suggests that 1H-NMR spectroscopy based metabolic profiling may be a promising, non-invasive tool to identify patients with SMA and for severity stratification, potentially complementing current diagnostic and prognostic strategies in SMA management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Atrophy, SpinalSeverity of Illness IndexHumansMaleFemaleChildChild, PreschoolAdolescentMetabolomicsBiomarkersMetabolomeInfantAdultProton Magnetic Resonance SpectroscopyMagnetic Resonance SpectroscopyBody FluidsMachine LearningYoung AdultPrognosis

Stichwörter der Autor:innen

1H-NMR spectroscopymetabolic profilingmetabolomicsspinal muscular atrophy

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Division of Child Neurology and Metabolic Medicine, Department of Pediatrics I, Center for Pediatrics and Adolescent Medicine, Medical Faculty Heidelberg, University Hospital Heidelberg, Heidelberg University, 69120 Hei…
  • Department of Pediatrics I, Center for Pediatrics and Adolescent Medicine, Medical Faculty Heidelberg, University Hospital Heidelberg, Heidelberg University, 69120 Heidelberg, Germany.
  • Bruker BioSpin GmbH & Co. KG, 76275 Ettlingen, Germany.
  • Department of Pediatrics, Division of Pediatric MUC iSPZ Hauner-Munich University Center for Children with Medical and Developmental Complexity, Dr. von Hauner Children's Hospital, LMU University Hospital, 80337 Munich,…
  • Department of Child Neurology, University Hospital Giessen, 35392 Giessen, Germany.
  • Department of Pediatrics, Neuropediatrics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

ORCID-Profile: Afshin Saffari, Moritz Niesert, Astrid Blaschek, Heike Kölbel, Georg F Hoffmann, Peter Claus, Stefan Kölker, Andreas Roos, Friedrich K Trefz, Markus Weiler, Jürgen G Okun, Andreas Ziegler

Förderung

  • Biogen (United States)
  • Dietmar Hopp Stiftung
  • Biogen, Inc., Cambridge, USA
  • Dietmar Hopp Stiftung, St. Leon Rot, Germany

Zitieren

APA

Saffari, A., Niesert, M., Cannet, C., Blaschek, A., Hahn, A., Johannsen, J., Kockaya, M., Kölbel, H., Hoffmann, G. F., Claus, P., Kölker, S., Müller-Felber, W., Roos, A., Schara-Schmidt, U., Trefz, F. K., Vill, K., Wick, W., Weiler, M., Okun, J. G., & Ziegler, A. (2024). Identification of Biochemical Determinants for Diagnosis and Prediction of Severity in 5q Spinal Muscular Atrophy Using 1H-Nuclear Magnetic Resonance Metabolic Profiling in Patient-Derived Biofluids. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212123

Vancouver

Saffari A, Niesert M, Cannet C, Blaschek A, Hahn A, Johannsen J, et al. Identification of Biochemical Determinants for Diagnosis and Prediction of Severity in 5q Spinal Muscular Atrophy Using 1H-Nuclear Magnetic Resonance Metabolic Profiling in Patient-Derived Biofluids. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212123

BibTeX
@article{Saffari2024,
  author = {Saffari, Afshin and Niesert, Moritz and Cannet, Claire and Blaschek, Astrid and Hahn, Andreas and Johannsen, Jessika and Kockaya, Musa and Kölbel, Heike and Hoffmann, Georg F and Claus, Peter and Kölker, Stefan and Müller-Felber, Wolfgang and Roos, Andreas and Schara-Schmidt, Ulrike and Trefz, Friedrich K and Vill, Katharina and Wick, Wolfgang and Weiler, Markus and Okun, Jürgen G and Ziegler, Andreas},
  title = {Identification of Biochemical Determinants for Diagnosis and Prediction of Severity in 5q Spinal Muscular Atrophy Using 1H-Nuclear Magnetic Resonance Metabolic Profiling in Patient-Derived Biofluids},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252212123}
}
Kostenlos starten →